BRPI1009325A2 - alvos para sinalização do fator de crescimento e método de terapia - Google Patents

alvos para sinalização do fator de crescimento e método de terapia

Info

Publication number
BRPI1009325A2
BRPI1009325A2 BRPI1009325A BRPI1009325A BRPI1009325A2 BR PI1009325 A2 BRPI1009325 A2 BR PI1009325A2 BR PI1009325 A BRPI1009325 A BR PI1009325A BR PI1009325 A BRPI1009325 A BR PI1009325A BR PI1009325 A2 BRPI1009325 A2 BR PI1009325A2
Authority
BR
Brazil
Prior art keywords
targets
growth factor
therapy method
factor signaling
signaling
Prior art date
Application number
BRPI1009325A
Other languages
English (en)
Inventor
Derek Van Lonkhuyzen
Gary Keith Shooter
Jesse Peet
Simone Rizzi
Tristan Croll
Zee Upton
Original Assignee
Univ Queensland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2009901181A external-priority patent/AU2009901181A0/en
Application filed by Univ Queensland filed Critical Univ Queensland
Publication of BRPI1009325A2 publication Critical patent/BRPI1009325A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/52—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving transaminase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/65—Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
BRPI1009325A 2009-03-19 2010-03-19 alvos para sinalização do fator de crescimento e método de terapia BRPI1009325A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2009901181A AU2009901181A0 (en) 2009-03-19 Targets for insulin-like growth factor signalling and methods of therapy
PCT/AU2010/000316 WO2010105302A1 (en) 2009-03-19 2010-03-19 Targets for growth factor signalling and methods of therapy

Publications (1)

Publication Number Publication Date
BRPI1009325A2 true BRPI1009325A2 (pt) 2016-03-08

Family

ID=42739049

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1009325A BRPI1009325A2 (pt) 2009-03-19 2010-03-19 alvos para sinalização do fator de crescimento e método de terapia

Country Status (11)

Country Link
US (1) US20120058120A1 (pt)
EP (1) EP2408471B1 (pt)
JP (1) JP2012520827A (pt)
KR (1) KR20110139736A (pt)
CN (1) CN102405056A (pt)
AU (1) AU2010225460B2 (pt)
BR (1) BRPI1009325A2 (pt)
CA (1) CA2755786A1 (pt)
NZ (1) NZ595731A (pt)
RU (1) RU2011142172A (pt)
WO (1) WO2010105302A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201209096D0 (en) 2012-05-24 2012-07-04 Medical Res Council Technology Compounds
EP3453722A1 (en) * 2017-09-06 2019-03-13 Julius-Maximilians-Universität Würzburg Pharmaceuticals and devices for the covalent immobilization to the extracellular matrix by transglutaminase
EP3569614A1 (en) * 2018-05-18 2019-11-20 Julius-Maximilians-Universität Würzburg Compounds and methods for the immobilization of myostatin-inhibitors on the extracellular matrix by transglutaminase
CN108653188B (zh) * 2018-08-21 2021-01-26 上海松皓生物科技有限公司 一种高效修复痘印的美容凝胶及制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6620596A (en) * 1996-07-25 1998-02-20 Victoria University Of Manchester, The Use of transglutaminase modulators to promote wound healing
GB0019302D0 (en) * 2000-08-08 2000-09-27 Univ Nottingham Trent Biological materials and the use thereof for the treatment of disease
AU2003900481A0 (en) 2003-02-05 2003-02-20 Queensland University Of Technology Synthetic modulators of cell migration and growth
CA2493655A1 (en) * 2004-01-29 2005-07-29 The University Of Manitoba Transglutaminase has intrinsic kinase activity
WO2006100679A2 (en) * 2005-03-22 2006-09-28 Quark Pharmaceuticals, Inc. Recombinant antibodies against human type ii transglutaminase and uses thereof
KR100838715B1 (ko) * 2005-12-16 2008-06-16 국립암센터 트란스글루타미나제를 억제하는 펩타이드
WO2007093008A1 (en) * 2006-02-17 2007-08-23 Adelaide Research & Innovation Pty Ltd Antibodies to insulin-like growth factor i receptor
US20080020982A1 (en) * 2006-07-21 2008-01-24 Patrice Delafontaine Methods and compositions for treatment of atherosclerosis
WO2008098129A2 (en) * 2007-02-07 2008-08-14 Indiana University Research And Technology Corporation Materials and methods for detecting and treating peritoneal ovarian tumor dissemination involving tissue transglutaminase
US8614233B2 (en) * 2007-05-29 2013-12-24 Universite De Montreal Cinnamoyl inhibitors of transglutaminase

Also Published As

Publication number Publication date
JP2012520827A (ja) 2012-09-10
RU2011142172A (ru) 2013-04-27
CA2755786A1 (en) 2010-09-23
AU2010225460A1 (en) 2011-11-03
US20120058120A1 (en) 2012-03-08
CN102405056A (zh) 2012-04-04
NZ595731A (en) 2013-09-27
WO2010105302A1 (en) 2010-09-23
EP2408471A1 (en) 2012-01-25
KR20110139736A (ko) 2011-12-29
AU2010225460B2 (en) 2014-05-01
EP2408471A4 (en) 2013-07-24
EP2408471B1 (en) 2015-06-24

Similar Documents

Publication Publication Date Title
DK2473116T3 (da) Knoglevækstindretning
HRP20171870T1 (hr) Sastavi i postupci za ubrzavanje rasta mišića
BRPI1012148A2 (pt) método e equipamento para preparar dentadura
GB201421783D0 (en) Target apparattus and method
IL233235A0 (en) Devices and methods for increasing bone growth
PL2482859T3 (pl) Sposób sterylizacji
BR112013007678A2 (pt) método para tratamento de doenças alérgicas
EP2566392A4 (en) SYSTEM AND METHOD FOR MATCHING ABDOMINAL SURFACES USING PSEUDO-CHARACTERISTICS
BR112013015870A2 (pt) método para o tratamento de biomassa e sistema
PT2523661T (pt) Inibidores de nkcc para o tratamento de autismo
EP2419041A4 (en) IMPLANT PLACEMENT SYSTEM
BR112012015322A2 (pt) propante e método para formar o propante
BR112013011930A2 (pt) sistema para a determinação da qualidade da estrutura óssea de um indivíduo
BRPI1012638A2 (pt) métodos e intermediários para preparar agentes farmacêuticos
UY33094A (es) Procedimiento para la preparacion de dronedarona
BR112013014442A2 (pt) micro-organismos para a produção de putrescina e método para a produção de putrescina utilizando o mesmo
BR112012033650A2 (pt) dispositivo e método para irrigação-evacuação de cavidades corporais
BRPI1006861A2 (pt) métodos para isolar bactérias
BR112012033133A2 (pt) aparelho e método para seleção de sementes
BR112014016108A2 (pt) método de tratamento de perda óssea alvelar
BR112013013765A2 (pt) método para inibição de crescimento de biofilme microbiano
FR2942407B1 (fr) Procede de photomaquillage et composition de photomaquillage
BR112013015249A2 (pt) aparelho marcador e método para operar aparelho marcador
EP2602605A4 (en) FABRIC EVALUATION DEVICE
SI2757878T1 (sl) Postopek za pripravo in nadgradnjo podkev

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]